Scholarly record
BIOFUNCTIONALIZED IRON OXIDE (II, III) NANOPARTICLES AS DIAGNOSTIC TOOLS FOR AUTOIMMUNE DISEASES
Abstract
Autoimmune diseases affect approximately 5% of the population worldwide. Generally, these disorders induce high degree of morbidity and disability and therefore, they have a significant social and economic impact. The precise diagnosis of specific autoimmune response is necessary for adequate treatment of the patient. Accordingly, the diagnostic assays for autoimmune diseases are continuously developing and improving. Biofunctionalized nanoparticles represent a promising novel approach in this field. Our group has developed a mechanism for efficient biofunctionalization of iron oxide (II, III) nanoparticles (ION) with molecules used for detection of biomarkers specific for rheumatoid arthritis. Purified biofunctionalized ION were tested with serum samples from healthy individuals, patients with rheumatoid arthritis and patients with another autoimmune disorder. We were able to detect rheumatoid arthritis-specific biomarkers using biofunctionalized ION. The efficiency of the nanoparticle-based assay was similar to the conventional enzyme-linked immunosorbent assay. Our results provide a basis for development of new utility models for rapid and sensitive diagnostic assays for autoimmune diseases.
Publication Impact Profile
Publication details
References0
Structured references will appear here after the reference import pass. The count is preserved now so the scholarly record is not incomplete.
View or Download full articleAccess options
SWS access login
Login as SWS Scientific CommitteeLogin as SWS Scientific PartnerLogin as SWS AuthorAuthors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.
For librarian assistance: [email protected]
Purchase Instant Access
- Article can be downloaded after successful payment.
- Article may be used according to SWS library access terms.
- Article cannot be redistributed.

